First-in-Human Study Finds Mechanical Circulatory Support and Renal Perfusion Success with the ModulHeart Device
September 19, 2022 — A first-in-human (FIH) study using the ModulHeart device (Puzzle Medical Devices Inc.) has demonstrated...
Search for Articles
Sep 19, 2022
Sep 16, 2022
HAYA Therapeutics Appoints Brian C. Thomas, Ph.D., as Chairperson of the Board of Directors
LAUSANNE, Switzerland and SAN DIEGO – Sept. 15, 2022 -- HAYA Therapeutics, SA, a company...
Sep 20, 2022
RapidPulse Raises Additional Funding for Ischemic Stroke Therapies and Notes Promising Results
MIAMI, Sept. 13, 2022 /PRNewswire/ -- RapidPulse, Inc., a privately-held medical device company developing a...
Aug 22, 2022
Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision...
Jul 13, 2022
Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...
Jul 13, 2022
Renovacor Announces Data from Pilot Pig Study Showing Successful Cardiac Transduction with REN-001 Delivered Via Low-Dose Retrograde Coronary Sinus Infusion Published in Journal of the American College of Cardiology: Basic to Translational Research
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...